bf/NASDAQ:BBGI_icon.jpeg

SHZ:300676

BGI Genomics

  • Stock

CNY

Last Close

10.05

25/09 14:00

Market Cap

17.76M

Beta: 0.58

Volume Today

19.64K

Avg: 7.31M

PE Ratio

124.18

PFCF: −10.68

Dividend Yield

2.67%

Payout:330.62%

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
-5.82B
-
1.35M
100.02%
1.38M
2.32%
3.40M
147.15%
5.46M
60.31%
4.57M
16.27%
3.33M
27.20%
3.00M
9.74%
3.27M
8.78%
4.56M
39.67%
average payables
1.42M
-
1.74M
23.23%
2.20M
26.17%
4.88M
121.65%
8.15M
66.97%
9.99M
22.66%
11.68M
16.91%
12.90M
10.38%
10.45M
18.98%
13.48M
28.98%
average receivables
17.69M
-
17.42M
1.52%
18.74M
7.61%
37.96M
102.51%
58.33M
53.69%
56.51M
3.13%
53.50M
5.33%
50.99M
4.69%
50.39M
1.18%
55.03M
9.22%
book value per share
4.12
-
5.72
38.96%
5.83
1.85%
8.51
46.05%
10.33
21.38%
10.02
3.01%
10.26
2.39%
9.43
8.08%
8.99
4.68%
7.54
16.16%
capex per share
-0.30
-
-0.14
53.75%
-0.11
21.64%
-0.14
31.31%
-0.63
333.12%
-0.16
74.30%
-0.33
102.54%
-0.26
19.11%
-0.15
41.64%
-0.45
194.92%
capex to depreciation
-3.11
-
-1.27
59.21%
-0.66
48.16%
-0.55
16.12%
-2.82
412.41%
-0.67
76.34%
-1.23
83.81%
-0.67
45.16%
-0.40
40.97%
-1.35
238.64%
capex to operating cash flow
-0.35
-
-0.19
45.37%
-0.18
7.38%
-0.20
14.24%
-0.62
208.67%
-0.18
70.75%
-0.43
137.83%
-1.77
312.44%
2.36
232.95%
-1.20
150.82%
capex to revenue
-0.07
-
-0.05
17.08%
-0.02
56.39%
-0.03
5.69%
-0.07
196.84%
-0.02
77.04%
-0.03
101.48%
-0.04
5.06%
-0.02
48.63%
-0.05
179.71%
cash per share
0.63
-
0.63
0.61%
0.62
0.02%
0.85
36.73%
0.50
41.17%
0.49
2.62%
0.67
37.38%
0.73
8.75%
1.76
140.07%
1.34
23.60%
days of inventory on hand
3.60K
-
248.09
93.11%
1.98K
697.60%
1.13K
-
10.32K
810.04%
1.67K
83.82%
302.57
81.88%
days payables outstanding
3.29K
-
525.01
84.04%
2.70K
414.26%
1.72K
-
35.75K
1,974.49%
5.94K
83.40%
1.62K
72.76%
days sales outstanding
59.83
-
109.66
83.29%
68.38
37.65%
149.73
118.98%
95.27
36.38%
74.30
22.01%
76.16
2.51%
83.92
10.18%
80.70
3.84%
80.70
0.00%
debt to assets
0.40
-
0.31
23.56%
0.28
8.66%
0.38
36.13%
0.33
14.67%
0.36
8.91%
0.39
9.90%
0.40
1.73%
0.43
8.47%
0.47
8.02%
debt to equity
1.14
-
0.75
34.44%
0.66
12.00%
1.26
90.75%
0.75
40.25%
0.88
17.88%
1.05
18.54%
1.10
5.08%
1.26
13.90%
1.49
18.74%
dividend yield
0.01
-
0.04
582.75%
0.05
42.33%
0.03
43.52%
0.01
51.10%
0.05
278.25%
0.06
23.47%
0.07
2.23%
earnings yield
0.06
-
0.34
489.87%
0.08
77.46%
0.32
319.66%
0.23
27.68%
0.06
73.18%
0.16
149.26%
-0.44
381.86%
-0.03
94.30%
-1.60
6,239.17%
enterprise value
291.06M
-
200.00M
31.28%
155.88M
22.06%
380.35M
144.00%
571.99M
50.39%
332.82M
41.81%
365.47M
9.81%
316.59M
13.37%
334.46M
5.64%
318.71M
4.71%
enterprise value over ebitda
10.44
-
20.56
96.95%
7.19
65.03%
12.91
79.59%
15.44
19.53%
7.35
52.42%
9.37
27.61%
36.71
291.70%
12.94
64.75%
12.02
7.15%
ev to operating cash flow
14.62
-
11.82
19.10%
10.85
8.28%
22.18
104.46%
20.41
7.95%
13.64
33.16%
17.41
27.61%
75.12
331.48%
-175.36
333.43%
28.59
116.30%
ev to sales
2.77
-
3.41
22.79%
1.47
56.81%
2.78
89.15%
2.46
11.48%
1.29
47.53%
1.40
8.10%
1.54
9.91%
1.39
9.80%
1.24
10.27%
free cash flow per share
0.57
-
0.60
5.02%
0.52
13.94%
0.58
11.47%
0.39
33.03%
0.73
88.57%
0.43
40.76%
-0.11
126.65%
-0.22
90.44%
-0.08
65.66%
free cash flow yield
0.07
-
0.12
79.42%
0.14
22.50%
0.09
34.93%
0.03
69.26%
0.19
573.82%
0.14
28.10%
-0.08
155.26%
-0.12
49.35%
-0.08
29.09%
graham net net
-6.27
-
-6.90
10.19%
-6.45
6.63%
-16.58
157.14%
-11.05
33.32%
-12.82
15.94%
-14.94
16.54%
-14.58
2.36%
-13.86
4.97%
-13.60
1.91%
graham number
6.86
-
15.03
119.04%
6.03
59.84%
19.55
224.04%
27.04
38.30%
7.30
73.02%
10.58
45.02%
11.83
11.77%
3.11
73.67%
15.80
407.38%
income quality
1.72
-
0.42
75.48%
2.26
434.21%
0.36
84.01%
0.32
10.96%
3.76
1,070.40%
1.57
58.33%
-0.22
114.24%
1.24
656.43%
-0.27
121.33%
intangibles to total assets
0.76
-
0.77
2.34%
0.77
0.17%
0.73
6.01%
0.77
6.22%
0.80
3.73%
0.76
5.36%
0.76
0.67%
0.73
3.65%
0.72
2.09%
0
100%
interest coverage
3.79
-
1.27
66.46%
3.44
170.68%
9.49
175.80%
3.30
65.20%
2.14
35.04%
2.11
1.42%
-0.15
106.93%
0.55
478.44%
0.62
11.34%
3.08
399.44%
interest debt per share
5.01
-
4.47
10.73%
4.01
10.34%
10.97
173.48%
8.42
23.25%
9.45
12.23%
11.41
20.76%
10.99
3.70%
12.19
10.91%
12.15
0.34%
inventory turnover
0.10
-
1.47
1,351.68%
0.18
87.46%
0.32
-
0.04
89.01%
0.22
517.98%
1.21
451.75%
invested capital
1.14
-
0.75
34.44%
0.66
12.00%
1.26
90.75%
0.75
40.25%
0.88
17.88%
1.05
18.54%
1.10
5.08%
1.26
13.90%
1.49
18.74%
market cap
198.48M
-
116.57M
41.27%
82.25M
29.44%
146.29M
77.86%
371.14M
153.69%
102.92M
72.27%
85.69M
16.74%
42.30M
50.64%
55.60M
31.46%
27.12M
51.22%
net current asset value
-134.73M
-
-149.89M
11.25%
-140.79M
6.07%
-355.76M
152.70%
-283.89M
20.20%
-335.11M
18.04%
-395.86M
18.13%
-393.99M
0.47%
-386.81M
1.82%
-379.63M
1.86%
net debt to ebitda
3.32
-
8.58
158.32%
3.40
60.40%
7.95
133.98%
5.42
31.79%
5.07
6.40%
7.18
41.42%
31.81
343.31%
10.79
66.08%
10.99
1.89%
net income per share
0.51
-
1.75
245.27%
0.28
84.16%
2.00
618.92%
3.15
57.58%
0.24
92.49%
0.49
105.39%
-0.66
235.91%
-0.05
92.73%
-1.47
2,970.49%
operating cash flow per share
0.88
-
0.74
15.35%
0.63
15.40%
0.72
14.95%
1.01
40.32%
0.89
12.14%
0.76
14.84%
0.15
80.39%
-0.07
143.90%
0.38
680.30%
payables turnover
0.11
-
0.70
526.41%
0.14
80.55%
0.21
-
0.01
95.18%
0.06
502.28%
0.23
267.13%
receivables turnover
6.10
-
3.33
45.44%
5.34
60.38%
2.44
54.33%
3.83
57.17%
4.91
28.22%
4.79
2.44%
4.35
9.24%
4.52
3.99%
4.52
0.00%
research and ddevelopement to revenue
return on tangible assets
0.18
-
0.56
212.39%
0.09
83.95%
0.26
191.70%
0.58
122.04%
0.05
91.82%
0.07
53.12%
-0.11
246.21%
-0.01
93.50%
-0.22
3,049.78%
revenue per share
4.61
-
2.57
44.23%
4.62
79.68%
5.75
24.25%
8.38
45.91%
9.38
11.92%
9.43
0.53%
7.26
23.01%
8.25
13.60%
8.70
5.44%
roe
0.12
-
0.31
148.46%
0.05
84.45%
0.23
392.23%
0.30
29.83%
0.02
92.26%
0.05
100.60%
-0.07
247.87%
-0.01
92.37%
-0.20
3,562.32%
roic
0.08
-
0.02
80.89%
0.04
146.55%
0.12
197.55%
0.27
133.24%
0.02
91.32%
0.04
72.37%
-0.00
107.94%
0.00
250.30%
0.02
301.90%
sales general and administrative to revenue
0.08
-
0.15
84.89%
0.08
44.21%
0.08
11.09%
0.07
9.55%
0.06
7.22%
0.08
28.17%
0.08
6.51%
0.07
9.43%
0.07
2.25%
shareholders equity per share
4.12
-
5.72
38.96%
5.83
1.85%
8.51
46.05%
10.33
21.38%
10.02
3.01%
10.26
2.39%
9.43
8.08%
8.99
4.68%
7.54
16.16%
stock based compensation to revenue
0.01
-
0.02
239.79%
0.01
53.21%
0.01
43.62%
0.01
26.92%
0.01
0.53%
0.01
7.20%
0.00
55.05%
0.01
57.36%
0.00
27.92%
tangible asset value
-106.18M
-
-114.00M
7.37%
-107.06M
6.09%
-278.01M
159.67%
-218.85M
21.28%
-269.90M
23.33%
-290.99M
7.81%
-295.91M
1.69%
-296.63M
0.24%
-286.58M
3.39%
tangible book value per share
-4.67
-
-5.00
7.01%
-4.67
6.50%
-11.69
150.11%
-7.90
32.39%
-9.83
24.47%
-10.49
6.70%
-10.42
0.66%
-10.14
2.76%
-9.72
4.07%
working capital
21.54M
-
21.51M
0.11%
26.18M
21.71%
69.47M
165.36%
55.70M
19.82%
42.09M
24.44%
26.47M
37.12%
37.07M
40.05%
67.70M
82.64%
48.97M
27.67%

All numbers in CNY (except ratios and percentages)